+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030- Product Image
Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030- Product Image
Sale

Global Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), ???? (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5924676
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023, USD 3.64 billion in 2024, and is expected to grow at a CAGR of 8.43% to reach USD 5.92 billion by 2030.

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supplies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • ????
    • Biologic Drugs
    • Medical Devices
    • Small-Molecules
  • Product
    • Auxiliary Medicinal Products
    • Interactive Response Technology (IRT) solutions
    • Lab Supplies
      • Centrifuges
      • Microscopes
      • Pipettes
      • Reagents
    • Medical Devices & Diagnostics
    • Pharmacy Supplies
      • Biohazard Bags
      • Compounding Aseptic Isolators
      • Sterilization Equipment
    • Research Materials
    • Safety Equipment
  • Therapeutic Area
    • Cardiology
    • Genetic Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
  • End User
    • Contract Research Organisations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Clinical Trial Supplies Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supplies Market?
  3. What are the technology trends and regulatory frameworks in the Clinical Trial Supplies Market?
  4. What is the market share of the leading vendors in the Clinical Trial Supplies Market?
  5. Which modes and strategic moves are suitable for entering the Clinical Trial Supplies Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Clinical Trial Supplies Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
5.1.2. Restraints
5.1.2.1. High cost of clinical trial supplies
5.1.3. Opportunities
5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
5.1.4. Challenges
5.1.4.1. Stringent regulations for clinical trial supplies
5.2. Market Segmentation Analysis
5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
5.2.2. ????: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
5.3. Market Trend Analysis
5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Clinical Trial Supplies Market, by Phase
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV
7. Clinical Trial Supplies Market, by ????
7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small-Molecules
8. Clinical Trial Supplies Market, by Product
8.1. Introduction
8.2. Auxiliary Medicinal Products
8.3. Interactive Response Technology (IRT) solutions
8.4. Lab Supplies
8.5.1. Centrifuges
8.5.2. Microscopes
8.5.3. Pipettes
8.5.4. Reagents
8.5. Medical Devices & Diagnostics
8.6. Pharmacy Supplies
8.7.1. Biohazard Bags
8.7.2. Compounding Aseptic Isolators
8.7.3. Sterilization Equipment
8.7. Research Materials
8.8. Safety Equipment
9. Clinical Trial Supplies Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiology
9.3. Genetic Diseases
9.4. Immunology
9.5. Infectious Diseases
9.6. Metabolic Disorders
9.7. Neurology
9.8. Oncology
10. Clinical Trial Supplies Market, by End User
10.1. Introduction
10.2. Contract Research Organisations
10.3. Pharmaceutical & Biotechnology Companies
11. Americas Clinical Trial Supplies Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Trial Supplies Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Trial Supplies Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
14.3.1.2. Sitero Acquires Clario’s eClinical Technology Suite to Enhance Clinical Trial Delivery
14.3.1.3. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
14.3.2.2. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
14.3.2.3. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
14.3.2.4. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
14.3.3. New Product Launch & Enhancement
14.3.3.1. Thermo Fisher Scientific Launches New Smart Refrigerator Series
14.3.3.2. BD Launches New Robotic System to Automate Clinical Flow Cytometry
14.3.4. Investment & Funding
14.3.4.1. Experic Closes USD 14 Million Series B Financing
14.3.4.2. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
14.3.5. Award, Recognition, & Expansion
14.3.5.1. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. 3M Company
15.1.2. Abbott Laboratories
15.1.3. Almac Group Limited
15.1.4. B. Braun SE
15.1.5. Baxter International, Inc.
15.1.6. Bayer AG
15.1.7. Becton, Dickinson and Company
15.1.8. Bio-Rad Laboratories, Inc.
15.1.9. Bruker Corporation
15.1.10. Cardinal Health, Inc.
15.1.11. Charles River Laboratories, Inc.
15.1.12. COREX LOGISTICS LIMITED
15.1.13. Emsere B.V by Medicapital Holdco B.V.
15.1.14. Eppendorf SE
15.1.15. Evident Corporation by Olympus Corporation
15.1.16. F. Hoffmann-La Roche Ltd.
15.1.17. Fujifilm Group
15.1.18. Hipro Biotechnology Co., Ltd.
15.1.19. Hitachi, Ltd.
15.1.20. HORIBA, Ltd.
15.1.21. ICON PLC
15.1.22. Immudex ApS
15.1.23. Incyte Corporation
15.1.24. IQVIA Inc.
15.1.25. Johnson & Johnson Services, Inc.
15.1.26. KLIFO A/S
15.1.27. Labnet International
15.1.28. Leica Microsystems GmbH by Danaher Corporation
15.1.29. llumina, Inc.
15.1.30. Lonza Group Ltd.
15.1.31. Medline Industries, LP
15.1.32. Merck KGaA
15.1.33. Myonex, LLC
15.1.34. Novo Nordisk A/S
15.1.35. Nuvisan GmbH
15.1.36. Parexel International Corporation
15.1.37. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
15.1.38. PerkinElmer Inc. by Revvity, Inc.
15.1.39. Pfizer Inc.
15.1.40. Promega Corporation
15.1.41. Recipharm AB
15.1.42. Rubicon Research Pvt. Ltd.
15.1.43. Sekisui Diagnostics Group
15.1.44. Sharp Services, LLC
15.1.45. Siemens Healthcare GmbH
15.1.46. Smith & Nephew PLC
15.1.47. Stryker Corporation
15.1.48. Thermo Fisher Scientific Inc.
15.1.49. Woodley Equipment Company Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
FIGURE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
FIGURE 4. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
FIGURE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2023 VS 2030 (%)
FIGURE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2019-2023
TABLE 3. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2019-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2019-2030 (USD MILLION)
TABLE 5. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 6. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2019-2030 (USD MILLION)
TABLE 7. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2019-2030 (USD MILLION)
TABLE 8. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2019-2030 (USD MILLION)
TABLE 9. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2019-2030 (USD MILLION)
TABLE 10. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 11. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2019-2030 (USD MILLION)
TABLE 12. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2019-2030 (USD MILLION)
TABLE 13. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2019-2030 (USD MILLION)
TABLE 14. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 15. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2019-2030 (USD MILLION)
TABLE 16. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2019-2030 (USD MILLION)
TABLE 17. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
TABLE 18. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 19. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2019-2030 (USD MILLION)
TABLE 20. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2019-2030 (USD MILLION)
TABLE 21. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2019-2030 (USD MILLION)
TABLE 22. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2019-2030 (USD MILLION)
TABLE 23. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2019-2030 (USD MILLION)
TABLE 24. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2019-2030 (USD MILLION)
TABLE 25. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 26. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2019-2030 (USD MILLION)
TABLE 27. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2019-2030 (USD MILLION)
TABLE 28. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
TABLE 29. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2019-2030 (USD MILLION)
TABLE 30. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2019-2030 (USD MILLION)
TABLE 31. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 32. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2019-2030 (USD MILLION)
TABLE 33. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2019-2030 (USD MILLION)
TABLE 34. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2019-2030 (USD MILLION)
TABLE 35. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2030 (USD MILLION)
TABLE 36. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2019-2030 (USD MILLION)
TABLE 37. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2030 (USD MILLION)
TABLE 38. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2030 (USD MILLION)
TABLE 39. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 40. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2019-2030 (USD MILLION)
TABLE 41. CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2030 (USD MILLION)
TABLE 42. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 43. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 44. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 45. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 46. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 47. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 48. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 49. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
TABLE 50. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 51. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 52. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 53. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 54. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 55. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 56. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 57. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 58. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 59. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 60. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 61. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 62. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 63. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 64. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 65. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 66. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 67. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 68. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 69. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 70. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 71. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 72. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 73. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 74. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 75. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 76. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 77. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 78. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 79. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 80. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 81. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 82. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 83. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 84. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2019-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
TABLE 94. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 95. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 96. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 97. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 98. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 99. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 100. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 101. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 102. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 103. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 104. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 105. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 106. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 107. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 108. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 109. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 110. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 111. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 112. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 113. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 114. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 115. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 116. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 117. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 118. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 119. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 120. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 121. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 122. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 123. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 124. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 125. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 126. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 127. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 128. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 129. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 130. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 131. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 132. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 133. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 134. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 135. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 136. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 137. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 138. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 139. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 140. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 141. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 142. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 143. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 144. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 145. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 146. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 147. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 148. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 149. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 150. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 151. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 152. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 153. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 154. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 155. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 156. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 157. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 158. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 159. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 160. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 161. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 162. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 163. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 164. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 165. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 166. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 167. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 168. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 169. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 170. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 171. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 172. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 173. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 174. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 175. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 176. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 177. VIETNAM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION)
TABLE 186. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 187. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 188. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 189. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 190. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 191. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 192. DENMARK CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 193. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 194. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 195. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 196. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 197. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 198. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 199. EGYPT CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 200. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 201. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 202. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 203. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 204. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 205. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 206. FINLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 207. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 208. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 209. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 210. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 211. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 212. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 213. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 214. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 215. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 216. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 217. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 218. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 219. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 220. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 221. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 222. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 223. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 224. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 225. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 226. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 227. ISRAEL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 228. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 229. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 230. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 231. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 232. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 233. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 234. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 235. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 236. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 237. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 238. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 239. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 240. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 241. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 242. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 243. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 244. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 245. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 246. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 247. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 248. NIGERIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 249. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 250. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 251. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 252. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 253. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 254. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 255. NORWAY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 256. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 257. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 258. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 259. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 260. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 261. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 262. POLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 263. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 264. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 265. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 266. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 267. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 268. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 269. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 270. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 271. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 272. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 273. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 274. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 275. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 276. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 291. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 292. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 293. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 294. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 295. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 296. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 297. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 298. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 299. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 300. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 301. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 302. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 303. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 304. SWEDEN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 305. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 306. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 307. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 308. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 309. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 310. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 311. SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 312. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 313. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 314. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 315. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 316. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 317. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 318. TURKEY CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2019-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ????, 2019-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2019-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2019-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2019-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2019-2030 (USD MILLION)
TABLE 332. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2019-2030 (USD MILLION)
TABLE 333. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 334. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 335. CLINICAL TRIAL SUPPLIES MARKET LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Almac Group Limited
  • B. Braun SE
  • Baxter International, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cardinal Health, Inc.
  • Charles River Laboratories, Inc.
  • COREX LOGISTICS LIMITED
  • Emsere B.V by Medicapital Holdco B.V.
  • Eppendorf SE
  • Evident Corporation by Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Group
  • Hipro Biotechnology Co., Ltd.
  • Hitachi, Ltd.
  • HORIBA, Ltd.
  • ICON PLC
  • Immudex ApS
  • Incyte Corporation
  • IQVIA Inc.
  • Johnson & Johnson Services, Inc.
  • KLIFO A/S
  • Labnet International
  • Leica Microsystems GmbH by Danaher Corporation
  • llumina, Inc.
  • Lonza Group Ltd.
  • Medline Industries, LP
  • Merck KGaA
  • Myonex, LLC
  • Novo Nordisk A/S
  • Nuvisan GmbH
  • Parexel International Corporation
  • Perceptive Informatics LLC and its affiliates, d/b/a Calyx
  • PerkinElmer Inc. by Revvity, Inc.
  • Pfizer Inc.
  • Promega Corporation
  • Recipharm AB
  • Rubicon Research Pvt. Ltd.
  • Sekisui Diagnostics Group
  • Sharp Services, LLC
  • Siemens Healthcare GmbH
  • Smith & Nephew PLC
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Woodley Equipment Company Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.92 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned49

Related Topics

Related Reports

Global Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Clinical Trial Supply & Logistics Market Size, Share & Trends Analysis Report by Service (Logistics & Distribution, Storage & Retention), Phase, Therapeutic Area, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 137 Pages
  • Global
From
Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030 - Product Image

Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030

  • Report
  • 184 Pages
  • Global
From
Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2023-2030 - Product Image

Global Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase, Sector, Therapeutic Area - Forecast 2023-2030

  • Report
  • 183 Pages
  • Global
From
Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023-2030 - Product Image

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 123 Pages
  • Global
From
Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028 - Product Image

Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Forecast to 2028

  • Report
  • 328 Pages
  • Global
From

About the Market

The Clinical Trial Supplies market is a subset of the Pharmaceuticals industry, focused on the production and distribution of materials used in clinical trials. These supplies can include drugs, medical devices, and other materials used to test the safety and efficacy of new treatments. Clinical trial supplies must meet strict regulatory requirements, and must be manufactured and distributed in a way that ensures the integrity of the trial results. The Clinical Trial Supplies market is highly competitive, with a number of companies offering a range of services. These include contract manufacturing organizations, packaging and labeling companies, and logistics providers. Companies in the market include Almac Group, Fisher Clinical Services, and PCI Pharma Services. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.